Form 4 for IGC IGC Pharma, Inc.
Accepted 2022-01-28 00:00:00 ET · period of report 2022-01-18 · accession 0001185185-22-000111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-28 | 2022-01-18 | IGC | Moran James P | Dir | A - Grant | $0.00 | +150.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Stock Units | 2022-01-18 | A | A | 100,000 | $0.00 | 150,000 | D | — | — | (F2) Represents 100,000 restricted shares of IGC common stock subject to vesting over two years in equal parts starting 2023, as per the RSU Agreement with Director Moran. |
| 2 | Common | Common Stock | 2022-01-18 | A | A | 50,000 | $0.00 | 50,000 | D | — | — | (F1) Represents 50,000 restricted shares of common stock vesting immediately as per the IGC Board of Directors Agreement with Mr. Moran. |